These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9617051)

  • 1. A study on the relation between proton pump inhibitor and gastric giardiasis.
    Kader SA; Mansour AM; Mohran Z; el-Taoil A; Abdalla KF
    J Egypt Soc Parasitol; 1998 Apr; 28(1):149-57. PubMed ID: 9617051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-pump inhibition and gastric giardiasis: a causal or casual association?
    Reynaert H; Fernandes E; Bourgain C; Smekens L; Devis G
    J Gastroenterol; 1995 Dec; 30(6):775-8. PubMed ID: 8963397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giardia lamblia trophozoites in gastric biopsies.
    Misra V; Misra SP; Dwivedi M; Singh PA
    Indian J Pathol Microbiol; 2006 Oct; 49(4):519-23. PubMed ID: 17183841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giardia lamblia and chronic gastritis.
    Sanad MM; Darwish RA; Nasr ME; el-Gammal NE; Emara MW
    J Egypt Soc Parasitol; 1996 Aug; 26(2):481-95. PubMed ID: 8754656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editor's quiz: GI snapshot. A rare infection of the gastric mucosa.
    Spiller R
    Gut; 2007 Aug; 56(8):1123, 1163. PubMed ID: 17625146
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic giardiasis--an association with proton pump inhibitors?
    Mukherjee S
    Am J Gastroenterol; 2000 Dec; 95(12):3666-7. PubMed ID: 11151928
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
    Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastrointestinal giardiasis associated with Helicobacter pylori].
    Isaeva GSh; Efimova NG
    Eksp Klin Gastroenterol; 2010; (6):30-4. PubMed ID: 20731162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel endoscopic findings in gastric giardiasis.
    Molina Infante J; Ferrando Lamana L
    Endoscopy; 2009; 41 Suppl 2():E275. PubMed ID: 19866426
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
    Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
    Müller P; Fuchs W; Peifer-Weiss A; Simon B
    Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastric giardiasis.
    Doglioni C; De Boni M; Cielo R; Laurino L; Pelosio P; Braidotti P; Viale G
    J Clin Pathol; 1992 Nov; 45(11):964-7. PubMed ID: 1452790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
    Mak SK; Loo CK; Wong AM; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
    Am J Kidney Dis; 2002 Sep; 40(3):576-81. PubMed ID: 12200810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?
    Kuipers EJ
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):187-94. PubMed ID: 16930292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
    Kuipers EJ; Lundell L; Klinkenberg-Knol EC; Havu N; Festen HP; Liedman B; Lamers CB; Jansen JB; Dalenback J; Snel P; Nelis GF; Meuwissen SG
    N Engl J Med; 1996 Apr; 334(16):1018-22. PubMed ID: 8598839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.